Table 5 Management and Clinical outcomes of patients diagnosed with MIS-C
Clinical Outcomes | N = 20 No. (%) |
|---|---|
Drug Therapy | Â |
Antibiotics | 16 (80.0) |
Intravenous Immunoglobulins | 2 (10.0) |
Systemic Steroids | 3 (15.0) |
NSAIDs | 5 (25.0) |
Non-invasive Oxygen therapy | 4 (20.0) |
Invasive Ventilation | 1 (5.0) |
Inotropic support | 1 (5.0) |
Admission to Intensive Care Unit | 4 (20.0) |
Discharged Home | 20.0 (100%) |
Death | 0.0 (0.0) |